MyAverix Finance
US · Healthcare
Immutep Limited (PRRUF)
Biotechnology
Immutep Limited (PRRUF) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for PRRUF
Immutep Limited (PRRUF) — FAQ
What is PRRUF's P/E ratio?
The price-to-earnings (P/E) ratio for Immutep Limited (PRRUF) is 25.00 (data as of 2026-05-23).
Does Immutep Limited pay a dividend?
Dividend yield is not available in the current snapshot for Immutep Limited (PRRUF). Check the MyAverix Finance app for the latest dividend data.
What sector is Immutep Limited in?
Immutep Limited (PRRUF) is classified in the Healthcare sector (Biotechnology industry).
What exchange is PRRUF listed on?
PRRUF is listed on US.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.